Rashid Maula Bux, University of Manitoba

Research

Biomarker Blood-Brain Barrier Drug Acetylation Early Detection Glioblastoma Metabolomics Spermine Spermidine Acetyl Transferase 1 Therapeutic Monitoring

Latest funding

Development and clinical assessment of novel biomarker drugs targeting SSAT1 for detection and therapeutic monitoring of glioblastoma
CIHR · 2018 · Principal investigator
$405,529

All 1 grants and awards

Development and clinical assessment of novel biomarker drugs targeting SSAT1 for detection and therapeutic monitoring of glioblastoma

Principal investigatorCIHR2018Collaborative Health Research Projects (NSERC partnered)

Principal investigators: Miller, Donald W; Maula Bux, Rashid A; Klonisch, Thomas; Lakowski, Ted M

Keywords: Biomarker; Blood-Brain Barrier; Drug Acetylation; Early Detection; Glioblastoma; Metabolomics; Spermine Spermidine Acetyl Transferase 1; Therapeutic Monitoring

$405,529

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Subject: Prospective PhD student: Biomarker Dear Professor Maula Bux, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on biomarker connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]